Risk Of Developing Liver Cancer After HCV Treatment

Tuesday, November 11, 2014

AASLD Conference Reports: HCV Data, slide presentations categorized by genotype and pharmaceutical company



65th Annual Meeting of the American Association for the Study of Liver Diseases

Comprehensive data investigating HCV interferon-free, ribavirin-free regimens presented at the liver meeting is now available on the website.

Updated daily, categorized by genotype and pharmaceutical company, with links to breaking news, clinical data, commentary and slide-sets from premier Hepatitis C websites.

Hepatitis C New Drug Research:  Conference Reports 


No comments:

Post a Comment